Trends in veterinary clinical and fundamental pharmacology: Past and future in the Netherlands

Veterinary Quarterly

Volumn 22, Issue 1, 2000, Pages 3-11

  van Miert, A S J P A M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Comparative pharmacokinetics and toxicokinetics; Good Veterinary Practice; Veterinary clinical pharmacology; Veterinary pharmacology; Veterinary pharmacy

Indexed keywords

DRUG;

ANIMAL DISEASE; DRUG DISPOSITION; DRUG RESEARCH; GOOD CLINICAL PRACTICE; NETHERLANDS; NONHUMAN; REVIEW;

ANIMAL DISEASES; ANIMALS; NETHERLANDS; PHARMACOKINETICS; PHARMACY; VETERINARY DRUGS; VETERINARY MEDICINE; XENOBIOTICS;

ANIMALIA;

EID: 0033968574     PISSN: 01652176     EISSN: 18755941     Source Type: Journal    
DOI: 10.1080/01652176.2000.9695015     Document Type: Review

References (108)

1. Anika SM, Nouws JFM, Vree TB, and Miert ASJPAM van. The efficacy and plasma disposition of chloramphenicol and spiramycin in tick-borne fever-infected dwarf goats. J Vet Pharmacol Ther 1986; 9: 433–5.
2. Baggot JD. Clinical pharmacokinetics in veterinary medicine. Clin Pharmacokinet 1992; 22: 254–73.
3. Baggot JD. Some aspects of drug persistence in domestic animals. Res Vet Sci 1970; 11: 130–7.
4. Baggot JD. Some aspects of veterinary pharmacology. In: Basic and Clinical Pharmacology (ed) B.G. Katzung, 2na edition, Lange Medical Publ., Los Altos, 1984: pp. 798–809.
5. Barragry TB. A review of the pharmacology and clinical uses of ivermectin. Can Vet J 1987; 28: 512–7.
6. Beck FJ, and Whitehouse MW. Impaired drug metabolism in rats associated with acute inflammation: a possible assay for anti-injury agents. Proc Soc Expl Biol Med 1974; 145: 135–40.
7. Bertz RJ, and Granneman GR. Use of in vitro and in vivo data to estimate the likelyhood of metabolic pharmacokinetic interactions. Clin Pharmacokinet 1997; 32: 210–58.
8. Bywater RJ, Hamilton P, and Palmer GH. Comparative bioavailability of two apparently similar injectable ampicillin formulations in pigs. Acta Vet Scand 1991: (Suppl. 87) pp. 374–5.
9. Caldwell J. Comparative aspects of drug conjugation in laboratory animals, exotic species and man. In: Comparative Veterinary Pharmacology, Toxicology and Therapy (eds) Miert ASJPAM van, Bogaert MG, and Debackere M, MTP-Press Ltd, Lancaster, UK, 1986: pp. 285–94.
10. Davis LE. Veterinary pharmacology: an introduction to the discipline. In: Veterinary Pharmacology and Therapeutics, 5th edition (eds) N.H. Booth and L.E. McDonald, Iowa State University Press, Ames, USA, 1982: pp. 1–7.
11. Derkx-Overduin LM. Slow-release phenytoin in canine epilepsy. Ph.D. thesis, Utrecht University, ISBN 90-393-0893-4, 1994.
12. Dorrestein GM. Studies on pharmacokinetics of some antibacterial agents in homing pigeons (Colombia livia). Ph.D. thesis Utrecht University, Optimax, Wijk bij Duurstede, 1986.
13. Duijkeren E van. Trimethoprim-sulfonamide combinations in relation to equine salmonellosis. Ph.D. thesis, Utrecht University, Elinkwijk Press, Utrecht ISBN 90-393-0517-X, 1995.
14. Ensink JM, Klein WR, Barneveld A, Miert ASJPAM van, and Vulto AG. Side effects of oral antimicrobial agents in the horse: a comparison of pivampicillin and trimethoprim/sulphadiazine. Vet Rec 1996; 138: 253–6.
15. Ensink JM. Pharmacokinetics and clinical aspects of oral broad-spectrum penicillines in the horse. Ph.D. thesis, Utrecht University, ISBN 90-393-0898-5, 1995.
16. Fink-Gremmels J, and Miert ASJPAM van. Species differences in biotransformation: Conventional models in unconventional animal species. Exp Toxicol Pathol 1996; 48 (11): 120–7.
17. Fink-Gremmels J, and Miert ASJPAM van. Veterinary drugs: disposition, biotransformation and risk evaluation. The Analist 1994; 119: 2521–8.
18. Fink-Gremmels J. Mycotoxins: Their implications for humanand animal health. Vet Quart 1999; 21: 115–20.
19. Firth EC, Nouws JFM, Driessens F, Schmaetz P, Peperkamp K, and Klein WR. Effect of the injection site of the pharmacokinetics of procaine penicillin G in horses. Am J Vet Res 1986; 47: 2380–4.
20. Frens J. Thermoregulation and fever. The influence of bacterial lipopolysaccharides on thennoregulation in the goat. Ph.D. thesis, Utrecht university, Elinkwijk Press, Utrecht, 1971.
21. Genderen H van. Farmacologie en Toxicologie, In: Van Gildestein naar Uithof: 150 jaar Diergeneeskundig Onderwijs in Utrecht, deel 2, (eds) Coffringa e.a. Rijksuniversiteit te Utrecht, Faculteit der Diergeneeskunde, Utrecht, 1981; 288–300.
22. Ghosh S, May MJ, and Kopp EB. NF-kappa B and Rel proteins: evolutionary conserved mediators of immune responses. Ann Rev Immunol 1998; 16: 225–60.
23. Gogh H van, Deurzen EJM van, Duin CTM van, and Miert ASJPAM van. Effect of staphylococcal enterotoxin Binduced diarrhoea on the pharmacokinetics of sulphadimidine in the goat. J Vet Pharmacol Ther 1984; 7: 303–5.
24. Gogh H van, Watson ADJ, Nouws JFM, Nieuwenhuijs J, and Miert ASJPAM van. Effect of tick-borne fever (Ehrlichia phagocytophila) and trypanosomiasis (Ttypanosoma brucei 1066) on the pharmacokinetics of sulfadimidine and its metabolites in goats. Drug Metab Dispos 1989; 17: 1–6.
25. Gogh H van. Pharmacokinetics of nine sulphonamides in goats. J Vet Pharmacol Therap 1980; 3: 69–81.
26. Groothuis DG, Werdler MEB, Miert ASJPAM van, and Duin CTM van. Factors affecting the absorption of ampicillin administered intramuscularly in dwarf goats. Res Vet Sci 1980; 29: 116–7.
27. Groothuis DG. Pharmacokinetics of some antimicrobial drugs in veal calves and their activity in relation to Salmonella dublin infections. Ph.D. thesis, Utrecht University, 1983.
28. Hammond RA, Hannon R, Frean S, Armstrong S, Flower RJ, and Bryant CE. Endotoxin induces nitric oxide synthase and cyclooxygenase-2 in equine alveolar macrophages. Am J Vet Res 1999; 60: 426–31.
29. Harris RZ, Benet LZ, and Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995; 50 222–39.
30. Hoebe KHW. Activated Kupffer cells: release of inflammatory mediators and their effects on acute phase proteins and hepatic drug metabolism (research project 1997-2001).
31. Hugnet C, Cadore JL, Buronfosse F, Pineau X, Mathet T, and Berny PJ. Loperamide poisoning in the dog. Vet Hum Toxicol 1996; 38: 31–3.
32. Izeboud CA. Activated macrophages (including Kupffer cells) and neutrophils: signal transduction and release of inflammatory mediators (research project 1996-2000).
33. Klooster GAE van’t, Blaauboer BJ, Noordhoek J, Miert ASJPAM van. Sulphadimidine metabolism in vitro; II: comparative studies in cultured rat, goat, sheep and cattle hepatocytes. J Vet Pharmacol Therap 1993; 16: 454–61.
34. Klooster GAE van’t, Drug metabolism in ruminants: an in vitro approach. Ph.D. thesis, Utrecht University, ISBN 90-393-0334-7, 1992.
35. Klooster GAE van’t, Horbach GJMJ, Natsuhori M., Blaauboer BJ, Noordhoek J, Miert ASJPAM van. Hepatic cytochrome P450 induction in goats; Effects of model inducers on the metabolism of alkoxyresorufins, testosterone and ethylmorphine and on apoprotein and mRNA levels. Biochem Pharmacol 1993; 45: 113–22.
36. Klooster GAE van’t, Woutersen-van Nijnanten FMA, Blaauboer BJ, Noordhoek J, and Miert ASJPAM van. The applicability of cultured hepatocytes derived from goats, sheep and cattle in comparative drug metabolism studies. Xenobiotica 1994; 24: 417–28.
37. Knoppert NW, Nijmeijer SM, Duin CTM van, Korstanje C, Gogh H van, and Miert ASJPAM van. Some pharmacokinetic data of aditoprim and trimethoprim in healthy and tick-borne fever infected dwarf goats. J Vet Pharmacol Therap 1988; 11: 135–44.
38. Ladage CA, Kleinepier JF, and Miert ASJPAM van. Some pharmacokinetic data of the liver-fluke anthelmintic nitroclofene in ruminant and pre-ruminant kids. J Vet Pharmacol Ther 1989; 12: 451–4.
39. Ladage CA, Walstijn THA van, and Riessen HA van. Comparative macroscopic evaluation of muscle damage in rats and in cattle after intramuscular administration of some commercially available injectable medicines. In: Trends in Veterinary Pharmacology and Toxicology (eds) Miert ASJPAM van, Frens J, and Kreek FW van der, Developments in Animal and Veterinary Sciences, Elsevier Sci Publ.Amsterdam 1980; vol. 6: pp. 34–40.
40. Ladage CA. The development of a new injectable anti-liver-fluke compound. Ph.D. thesis, Utrecht University, ACF Chemiefarma Press, Maarssen, 1979.
41. Lee RM, and Pickering WR. The toxicity of haloxon to geese, ducks and hens, and its relationship to the stability of the di-(2-chloro-ethyl) phosphoryl cholinesterase derivatives. Biochem Pharmacol 1967; 16: 941–8.
42. Lees P, Armstrong S, Frean S, Landoni MF, and Shojaee Ali-Abadi F. Pharmacology, toxicology and therapeutic uses of NSAIDs. Proc. EAVPT-ECVPT workshop on animal pain and inflammation and their control., Dec 14-18th, 1998, Hatfield, UK, pp: 93–115.
43. Lohse MJ. The future of pharmacology. Trends Pharmacol Sci (TIPS) 1998; 19: 198–200.
44. Lohuis JACM, Werven T van, Brand A, Miert ASJPAM van, Rohde E, Ludwig B, Heizmann P, and Rehm W.F. Pharmacodynamics and pharmacokinetics of carprofen, a non-steroidal anti-inflammatory drug, in healthy cows and cows with Escherichia coli endotoxin-induced mastitis. J Vet Pharmacol Ther 1991; 14: 219–29.
45. Lohuis JACM. Escherichia coli mastitis in the cow. Some aspects of symptomatic treatment and defence mechanisms. Ph.D. thesis, Utrecht University, Elinkwijk Press, Utrecht, 1989.
46. Maas CL. Modulation of forestomach motility in small ruminants: opioid and nonopioid mechanisms. Ph.D. thesis, Utrecht University, Elinkwijk Press, Utrecht, 1984.
47. May MJ, and Ghosh S. Rel/NF-kappa B and I kappa B proteins: an overview. Cancer Biol 1997; 8: 63–73.
48. Mengelers MJB, Kleter GA, Hoogenboom LAP, Kuiper HA, and Miert ASJPAM van. The biotransformation of sulfadimethoxine, sulfadimidine, sulfamethoxazole, trimethoprim and aditoprim by primary cultures of pig hepatocytes. J Vet Pharmacol Ther 1997; 20, 24–32.
49. Mengelers MJB. The prophylaxis of pleuropneumonia in pigs with sulfonamide-trimethoprim combinations: microbiological, pharmacokinetic and residual aspects. Ph.D. thesis, Utrecht University, 1991.
50. Mevius DJ. Microbiological and pharmacokinetical aspects of flumequine in healthy and diseased calves. Ph.D. thesis, Utrecht University, Addix, Wijk bij Duurstede, 1990.
51. Miert ASJPAM van, and Duin CTM van. Pharmacological and pathophysiological modulation of food intake and forestomach motility in small ruminants. J Vet Pharmacol Therap 1998; 21: 1–17.
52. Miert ASJPAM van, and Duin CTM van. The effect of flurbiprofen upon fever and ruminal stasis induced by Escherichia coli endotoxin, Poly I: Poly C and sodium nucleinate from yeast in conscious goats. J vet Pharmacol Therap 1979; 2: 69–79.
53. Miert ASJPAM van, Duin CTM, and Wensing T. Effects of flurbiprofen on recombinant human IL-1 a-induced fever and associated clinical, haematological and blood biochemical changes in the dwarf goat. Vet Quart 1994; 16: 1–6.
54. Miert ASJPAM van, Peters RHM, Basudde CDK, Nijmeijer SM, Duin CTM van, Gogh H van, and Korstanje C. Effect of trenbolone and testosterone on the plasma elimination rates of sulfamethazine, trimethoprim, and antipyrine in female dwarf goats. Am J Vet Res 1988; 49: 2060–4.
55. Miert ASJPAM van. ‘Off-label use’ van lincomycine-hydrochloride bij twee paarden. Dysbacteriose en daarbij optredende fatale complicaties door insufficiente symptomatische therapie. Tijdschr Diergeneeskd 1995; 120: 361–3.
56. Mien ASJPAM van. Van Materia medica tot rationele farmacotherapie. Tijdschr Diergeneeskd 1984; 109: 3–11.
57. Miert ASJPAM van. Acute phase response and non cellular defence mechanisms. In: Burvenich C, Vandeputte-Van Messon G and Hill AW (eds). New Insights Into The Pathogenisis of Mastitis. Ghent: Vlaams Diergeneeskd Tijdschr 1991; 62; 69–91.
58. Mien ASJPAM van. Cytokines as inflammatory mediators Proc. EAVPT-ECVPT workshop on animal pain and inflammation and their control, Dec. 14-18th, 1998, Hatfield, UK, pp. 5–6.
59. Miert ASJPAM van. Efficacy of drugs and good veterinary practice. In: Residues of Veterinary Drugs and Mycotoxins in Animal Products (eds) Enne G, Kuiper HA, and Valentini A. Wageningen Press. Wageningen 1996: pp. 87–94.
60. Miert ASJPAM van. Extrapolation of pharmacological and toxicological data based on metabolic weight. Arch experim Veterinärmedizin (Leipzig) 1989; 43: 481–8.
61. Miert ASJPAM van. Good Veterinary Practice (GVP) and the prevention of drug residues in food products of animal origin. Proc. World Congress on Food Hygiene, August 24-29, 1997 Wageningen Press pp. 103.
62. Miert ASJPAM van. Good Veterinary Practice and efficacy. Proc. Int. Conf. Veterinary Medicine in post-1992. Europe, Brussels February 13-14, Belgium, 1992: pp 84–98.
63. Miert ASJPAM van. Herman van Genderen Symposion. Vet Quart 1981; 3: 165–8.
64. Miert ASJPAM van. Influence of febrile disease on pharmacokinetics of veterinary drugs. Ann Rech Vet 1990; 21 (suppl. 1): 21S-8S.
65. Miert ASJPAM van. Inhibition of reticulo-rumen motility during fever induced by bacterial pyrogen lipopolysaccharides from gram-negative bacteria - in sheep and goats. PhD thesis, Utrecht University, Grosfeld Offset, Berlicum, 1970.
66. Miert ASJPAM van. Pro-inflammatory cytokines in a ruminant model: pathophysiological, pharmacological and therapeutic aspects. Vet Quart 1995; 17, 41–50.
67. Miert ASJPAM van. The use in animals of drugs licensed for human use only. In: Comparative Veterinary Pharmacology, Toxicology and Therapy (eds.) Miert ASJPAM van, Bogaert MG, and Debackere M, MTP Press Ltd., Lancaster, 1986, pp. 489–500.
68. Miert ASJPAM van. Veterinary drugs and good veterinary practice (Diergeneesmiddelen en ‘good veterinary practice’). Tijdschr Diergeneeskd 1990; 115: 125–31.
69. Mien ASJPAM van. Veterinary pharmacotherapy: from retrospect to future expectations (Veterinaire farmacotherapie: van terugblik naar toekomstverwachting). Tijdschr Diergeneeskd 1987; 112: 836–43.
70. Monshouwer M, Witkamp RF, Leengoed LAMG van, Vernooy JCM, Verheijden JHM, and Miert ASJPAM van. A lipopolysaccharide-induced acute phase response in the pig is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism. J Vet Pharmacol Ther 1996; 19: 382–8.
71. Monshouwer M, Witkamp RF, Nijmeijer SM, Amsterdam, JG van, and Miert ASJPAM van. Suppression of cytochrome P450-and UDP glucuronosyl transferasedependent enzyme activities by proinflammatory cytokines and possible role of nitric oxide in primary cultures of pig hepatocytes. Toxicol Appl Pharmacol 1996; 137: 237–44.
72. Monshouwer M, Witkamp RF, Nijmeijer SM, Leengoed LAMG van, Verheijden JHM, and Miert ASJPAM van. Infection (Actinobacillus pleuropneumoniae) mediated suppression of oxidative hepatic drug metabolism and cytochrome P4503A mRNA levels in the pig. Drug Metab Dispos 1995; 23: 44–7.
73. Monshouwer M, Witkamp RF, Nijmeijer SM, Pijpers A, Verheijden JHM, and Miert ASJPAM van. Selective effects of a bacterial infection model (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, antipyrine, paracetamol, and indocyanine green in the pig. Xenobiotica 1995; 25: 491–9.
74. Monshouwer M. Acute phase response mediated effects on hepatic drug metabolism in pigs: an in vivo and in vitro approach. Ph.D. thesis, Utrecht University, ISBN 90-393-1432-2, 1996.
75. Monshouwer M, Klooster GAE van’t, Nijmeijer SM, Witkamp RF, and Miert ASJPAM van. Characterization of cytochrome P450 isoenzymes in primary cultures of pig hepatocytes. Toxicol in Vitro 1998; 12: 715–23.
76. Natsuhori M, Raak M van, Ligtenberg M, Kleij LA, Berge D ten, Zweers-Zeilmaker WM, Groene EM de, Miert ASJPAM van, Witkamp RF, and Horbach GJ. Isolation of a bovine full length cytochrome P450 (CYP3A) cDNA sequence and its functional expression in V79 cells. Environm Toxicol Pharmacol 1997; 3: 17–24.
77. Nijmeijer SM, Samuriwo E, Duin CTM van, and Miert ASJPAM van. Oral chloramphenicol in dwarf goats. Influence of vasopressin on its absorption and effect of diet on its biodegradation in ruminal fluid samples. J Vet Pharmacol Ther 1990; 13: 408–17.
78. Noach EL. Pharmacology in the Netherlands. XI th International Congress of Pharmacology, July 1-6, Amsterdam, 1990.
79. Noach EL. The history of pharmacology in the Netherlands. Trends Pharmacol Sci (TIPS) 1990; 11: 236–9.
80. Nouws JFM, Smulders A, and Rappalini MA. comparative study on irritation and residue aspects of five oxytetracycline formulations administered intramuscularly to calves, pigs and sheep. Vet. Quart 1990; 12: 129–38.
81. Nouws JFM. Tissue distribution and residues of some antimicrobial drugs in normal and emergency-slaughtered ruminants. Ph.D. thesis, Utrecht University, 1978.
82. Os JL van. Oestrus control in the bitch with proligestone Ph.D. thesis, Utrecht University, 1982.
83. Park GR. Pharmacokinetics and pharmacodynamics in the critically ill patient. Xenobiotica 1993; 23: 1195–1230.
84. Pickering WR, and Malone JC. The acute toxicity of dichloroalkyl aryl phosphates in relation to chemical structure. Biochem Pharmacol 1967; 16: 1183–94.
85. Pijpers A, Schoevers EJ, Gogh H van, Leengoed LAMG van, Visser IJR, Mien ASJPAM van, and Verheijden JHM. The influence of disease on feed and water consumption and on pharmacokinetics of orally administered oxytetracycline in pigs. J Anim Sci 1991; 69: 2947–54.
86. Pijpers A. Feed medication with tetracyclines in pigs: a critical evaluation. Ph.D. thesis, Utrecht University, 1990.
87. Pulliam JD, Seward RL, Henry RT, and Steinberg SA. Investigating ivermectin toxicity in collies. Vet Med 1985; 80: 33–40.
88. Rasmussen F, and Svendsen O. Tissue damage and concentration at the injection site after intramuscular injection of chemotherapeutics and vehicles in pigs. Res Vet Sci 1976; 20: 55–60.
89. Rasmussen F. Renal clearance: species differences and similarities. Vet Res Commun 1983; 7: 301–6.
90. Rasmussen F. Tissue damage at le injection site after intramuscular injection of drugs in food-producing animals. In: Trends in Veterinary Pharmacology and Toxicology (eds) Miert ASJPAM van, Frens J, and Kreek FW van der. Developments in Animal and Veterinary Sciences Vol. 6, Elsevier Sci. Publ. Amsterdam 1980: pp. 27–33.
91. Roy TAJM de. Dopamine in central thermoregulation. A comparative study in the goat, sheep and rabbit. Ph.D. thesis, Utrecht University, 1978.
92. Rutgers LJE, Miert ASJPAM van, Nouws JFM, and Ginneken CAM van. Effect of the injection site on the bioavailability of amoxicillin trihydrate in dairy cows. J Vet Pharmacol Therap 1980; 3: 125–32.
93. Schinkel AH, Smit JJM, Tellingen O van, Beynen JH, Wagenaar E, Deemter L van, Mol CAAM, Valk MA van der, Robanus-Maandag EC, Riele HPJ te, Berns AJM, and Borst P. Disruption of the mouse mdr 1 a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994; 77: 491–502.
94. Vane J. The mechanism of action of anti-inflammatory drugs. Naunyn-Schmiedeberg’s Arch Pharmacol 1998; 385 (1): R8.
95. Veenendaal GH. Role of circulating inflammatory mediators during ruminal stasis induced by experimental fever in goats. Ph.D. thesis, Utrecht University, Elinkwijk Press, Utrecht, 1979.
96. Verheijden JHM. Further investigations into some aspects of acute coliform mastitis in cattle. Ph.D thesis, Utrecht University, 1979
97. Villar D, Furusawa N, Monshouwer M, and Miert ASJPAM van. Novobiocin inhibits both UDP-glucuronosyltransferase and cytochrome P450-mediated enzyme activities in pig liver microsomes. Vet Res Commun 1998; 22: 405–14.
98. Walker CH. Hepatic microsomes as models for comparative metabolism in vivo. In: Comparative Veterinary Pharmacology Toxicology and Therapy (eds) Miert ASJPAM van, Bogaert MG, and Debackere M. MTP-Press, Ltd, Lancaster, UK, 1986: pp 295–9.
99. Wit JG. Institute of veterinary pharmacology, pharmacy and toxicology: its research (1961-1980). Vet Quart 1981; 3: 169–75.
100. Witkamp RF, Klooster GAE van’t, Nijmeijer SM, Kolker HJ, Noordhoek J, and Miert ASJPAM van. Hormonal regulation of oxidative drug metabolism in the dwarf goat: the effect of sex and hormonal treatment on plasma and metabolite formation of sulphadimidine. J Vet Pharmacol Therap1993; 16: 55–62.
101. Witkamp RF, Nijmeijer SM, Csiko G, and Miert ASJPAM van. Tiamulin selectively inhibits oxidative hepatic steroid and drug metabolism in vitro in the pig. J Vet Pharmacol Therap 1994; 17: 317–22.
102. Witkamp RF, Nijmeijer SM, Duin CTM van, Noordhoek J, and Miert ASJPAM van. The regulation of oxidative drug metabolism by growth hormone in the dwarf goat: differences from and similarities to the mechanism in rats. J Endocrinol 1993; 136: 313–7.
103. Witkamp RF, Nijmeijer SM, Kolker HJ, Noordhoek J, and Miert ASJPAM van. Effect of gonadal hormones on the plasma clearance and metabolite formation of antipyrine in dwarf goat. J Vet Pharmacol Therap 1993; 16: 164–73.
104. Witkamp RF, Nijmeijer SM, Monshouwer M, and Miert ASJPAM van. The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig. Drug Metab Dispos 1995; 23: 542–7.
105. Witkamp RF. Cellular communication and signal transduction in inflammatory processes: therapeutic targets. Proc. EAVPT-ECVPT workshop on animal pain and inflammation and their control, Dec 14-18th, 1998, Hatfield, UK, pp 66–83.
106. Witkamp RF. Oxidative drug metabolism in ruminants and laboratory species. Comparative aspects and regulation by steriod hormones and somatotropin. Ph.D. thesis, Utrecht University, ISBN 90-393-0301-0, FEBO Press, Enschede, 1992.
107. Zweers-Zeilmaker WM, Batzias J, Maas RFM, Horbach GJ, Miert ASJPAM van, and Witkamp RF. In vitro and in vivo oxidative biotransformation in the West-African dwarf goat (Caprus hircus aegagrus): substrate activities and effects of inducers. Xenobiotica 1996; 26: 1131–41.
108. Zweers-Zeilmaker WM. Cytochrome P450 in ruminants. Drug metabolism and drug-drug interactions. Ph.D. thesis, Utrecht University, ISBN 90-393-1408-X, 1997.